Related Experiment Video
Updated: Jun 13, 2026
Evaluation of Left Ventricular Structure and Function using 3D Echocardiography
Published on: October 28, 2020
Echocardiographic quantification of left ventricular mass: prognostic implications
Rajiv S Swamy1, Roberto M Lang
1University of Chicago Medical Center, 5841 South Maryland Avenue, MC 5084, Chicago, IL 60637, USA. rajiv.swamy@uchospitals.edu
Insights
Left ventricular hypertrophy (LVH) is a cardiac risk factor, but lacks standardized monitoring. This review details current echocardiography methods for LVH detection and therapeutic targeting.
Area of Science:
- Cardiology
- Medical Imaging
Background:
- Left ventricular hypertrophy (LVH) is an independent risk factor for cardiac and cerebrovascular events.
- Standardized quantification and monitoring of LVH regression remain challenging, limiting its clinical utility.
- Echocardiography is the primary tool for LVH assessment.
Purpose of the Study:
- To provide a current appraisal of left ventricular hypertrophy (LVH).
- To highlight current clinical methods for accurate LVH detection.
- To discuss the prognostic implications of LVH and establish therapeutic targets.
Main Methods:
- Review of current echocardiographic techniques for LVH quantification.
- Analysis of established reference standards for LVH assessment.
- Evaluation of clinical data on LVH regression and its prognostic impact.
Main Results:
- Echocardiography offers improved quantification of LVH.
- Reference standards aid in determining the clinical significance of LVH regression.
- Accurate detection and monitoring are crucial for risk stratification.
Conclusions:
- Standardized LVH assessment is essential for clinical application.
- Echocardiography plays a vital role in managing LVH.
- Developing therapeutic targets for LVH regression is a key clinical goal.
Abstract:
Left ventricular hypertrophy (LVH) has been shown to be an independent risk factor for adverse cardiac and cerebrovascular events. Despite this well-known association, the lack of a standardized approach for the quantification and the monitoring of LVH regression has limited its use as a primary risk factor that can be easily clinically targeted. Echocardiography has become the most widespread tool used for the quantification of LVH. With advances in this technology, echocardiographic quantification of LVH has improved and reference standards are being used to determine the clinical implications of LVH regression. In this article, we aim to provide a current appraisal of LVH with a focus on presenting the current clinical methods used to accurately detect LVH, the prognostic implications of these findings, and help develop a therapeutic target for clinicians.
